Education
About Us
Working with TipRanks
Follow Us
PharmaTher Holdings Ltd (TSE:PHRM)
:PHRM
RESEARCH TOOLSreports
Total Valuation
PharmaTher Holdings Ltd has a market cap or net worth of $20.36M. The enterprise value is C$3.78M.
Market Cap$20.36M
Enterprise ValueC$3.78M
Share Statistics
PharmaTher Holdings Ltd has 88,519,066 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding88,519,066
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PharmaTher Holdings Ltd’s return on equity (ROE) is -1.33 and return on invested capital (ROIC) is -128.22%.
Return on Equity (ROE)-1.33
Return on Assets (ROA)-1.20
Return on Invested Capital (ROIC)-128.22%
Return on Capital Employed (ROCE)-1.30
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PharmaTher Holdings Ltd is -5.66. PharmaTher Holdings Ltd’s PEG ratio is -0.03.
PE Ratio-5.66
PS Ratio0.00
PB Ratio1.79
Price to Fair Value7.55
Price to FCF-3.00
Price to Operating Cash Flow-3.00
PEG Ratio-0.03
Income Statement
In the last 12 months, PharmaTher Holdings Ltd had revenue of 0.00 and earned -3.12M in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit-711.00
Operating Income-3.04M
Pretax Income-3.12M
Net Income-3.12M
EBITDA-3.04M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -1.70M and capital expenditures 0.00, giving a free cash flow of -1.70M billion.
Operating Cash Flow-1.70M
Free Cash Flow-1.70M
Free Cash Flow per Share-0.02
Dividends & Yields
PharmaTher Holdings Ltd pays an annual dividend of C$0.027, resulting in a dividend yield of ―
Dividend Per ShareC$0.027
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.26
52-Week Price Change6.82%
50-Day Moving Average0.21
200-Day Moving Average0.22
Relative Strength Index (RSI)59.56
Average Volume (3m)59.95K
Important Dates
PharmaTher Holdings Ltd upcoming earnings date is Sep 25, 2025, TBA Not Confirmed.
Last Earnings DateApr 28, 2025
Next Earnings DateSep 25, 2025
Ex-Dividend DateMar 30, 2023
Financial Position
PharmaTher Holdings Ltd as a current ratio of 9.25, with Debt / Equity ratio of 0.00%
Current Ratio9.25
Quick Ratio9.25
Debt to Market Cap0.00
Net Debt to EBITDA0.70
Interest Coverage Ratio0.00
Taxes
In the past 12 months, PharmaTher Holdings Ltd has paid -48.73K in taxes.
Income Tax-48.73K
Effective Tax Rate0.02
Enterprise Valuation
PharmaTher Holdings Ltd EV to EBITDA ratio is -5.10, with an EV/FCF ratio of -4.40.
EV to Sales0.00
EV to EBITDA-5.10
EV to Free Cash Flow-4.40
EV to Operating Cash Flow-4.40
Balance Sheet
PharmaTher Holdings Ltd has $1.55M in cash and marketable securities with C$0.00 in debt, giving a net cash position of -$1.55M billion.
Cash & Marketable Securities$1.55M
Total DebtC$0.00
Net Cash-$1.55M
Net Cash Per Share-$0.02
Tangible Book Value Per Share$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PharmaTher Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast66.13%